The Covid-19 pandemic put thousands of clinical trials on hold, but it also showed pharma companies, regulators and clinicians that decentralized clinical trials are a less expensive, more convenient and equally as effective method for generating clinical research. Dessiree Paoli, Sr. Solutions Marketing Manager for Interlace Health, joined The Healthcare Solutions Podcast to discuss how decentralized clinical trials are improving engagement with study participants, improving data capture and shortening time to market for crucial drugs.
Support remote clinical trials with Interlace Health
Interlace Health’s Clinical Trial Consent Solution provides the digital platform to collect and store consent of clinical trial participants and serves as a portal to access vital educational content needed to understand trial requirements.